Skip to content

News

Ovarian Cancer Awareness Month

Ovarian Cancer Awareness Month

September is the official month for Ovarian Cancer Awareness. Ovarian Cancer Awareness Month is our time to spread the word about risk and prevention, rally for more scientific research, and make progress toward a cure. Read on for ways you can be an ambassador for Ovarian Cancer Awareness Month! Here’s how you can make a … Continued

Can a Pap Smear Detect Ovarian Cancer? A Comprehensive Look

Can a Pap Smear Detect Ovarian Cancer? A Comprehensive Look

No, a Pap smear does not test for ovarian cancer; it screens for cervical cancer. In fact, no reliable screening or early detection tests exist for ovarian cancer. What is a Pap Smear? In the realm of women’s health, a prevalent question emerges: “Does a Pap smear reveal ovarian cancer?” This inquiry stems from a … Continued

The Overview: July 2023

The Overview: July 2023

OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy options for ovarian cancer patients. Learn more about the findings from the research team, which included Dr. Bob McGray, OCRA grantee, and Dr. Kunle Odunsi, … Continued

Study: Gynecologic Cancer Survivors Fear Recurrence Regardless of Prognosis

Study: Gynecologic Cancer Survivors Fear Recurrence Regardless of Prognosis

A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of fear of recurrence among gynecologic cancer survivors, regardless of their prognosis, and underscores the importance of support programs to address survivors’ needs adequately. Through in-depth … Continued

Jill McGill Raises Awareness at U.S. Women’s Open at Pebble Beach

Jill McGill Raises Awareness at U.S. Women’s Open at Pebble Beach

Jill McGill, reigning champion of the U.S. Senior Women’s Open, continued to champion the ovarian cancer cause at last week’s U.S. Women’s Open at Pebble Beach, handing out special ball-markers featuring her signature on one side, and a QR code leading to OCRA’s website on the other. McGill’s campaign to make a difference is in … Continued

Overcoming Racial Disparities in Genetic Testing

Overcoming Racial Disparities in Genetic Testing

In a new article published in Everyday Health, experts spoke about the disparities Black Americans face when diagnosed with ovarian cancer, exploring reasons why these disparities may exist, and offering recommendations for Black individuals who are diagnosed with ovarian, fallopian tube, or primary peritoneal cancer. In particular, Black Americans should be aware of the importance … Continued

The Overview: June 2023

The Overview: June 2023

Update to Clinical Guidelines: Special Circumstance Chemotherapy Approvals Last month, we reported news of an ongoing shortage of chemotherapy drugs essential to ovarian cancer treatment. Though the shortage continues, patients affected now have more options. In early June, the National Comprehensive Care Network’s (NCCN) Clinical Practice Guidelines were updated to approve oxaliplatin-based regimens like docetaxel / oxaliplatin … Continued

Special Summer Programming Offers Support and Opportunities to Connect

Special Summer Programming Offers Support and Opportunities to Connect

Summer is officially here! Strengthen your connection to community this season with special support offerings, interactive roundtables and summer-themed sessions for those impacted by ovarian and other gynecologic cancers. And no need to leave the comfort of your climate-controlled home to attend — all meetings will be held online. “This summer, we’re offering more choices … Continued

Ask the SAC | Multi-Cancer Detection Tests and Ovarian Cancer

Ask the SAC | Multi-Cancer Detection Tests and Ovarian Cancer

Share your thoughts on multi-cancer detection tests and what role they might have, or not, for ovarian cancer? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of letters of … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.